(NASDAQ: NUWE) Nuwellis's forecast annual revenue growth rate of 41.43% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.01%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.84%.
Nuwellis's revenue in 2025 is $8,740,000.On average, 1 Wall Street analysts forecast NUWE's revenue for 2025 to be $47,545,228, with the lowest NUWE revenue forecast at $47,545,228, and the highest NUWE revenue forecast at $47,545,228. On average, 1 Wall Street analysts forecast NUWE's revenue for 2026 to be $70,683,614, with the lowest NUWE revenue forecast at $70,683,614, and the highest NUWE revenue forecast at $70,683,614.
In 2027, NUWE is forecast to generate $111,011,765 in revenue, with the lowest revenue forecast at $111,011,765 and the highest revenue forecast at $111,011,765.